125I-radiolabeling

JM Masson, R Labia. Synthesis of a 125I-radiolabeled penicillin for penicillin-binding proteins studies. Anal Biochem 128 164-168, 1983. 

Antibody. Rat monoclonal antibody 34A was purified from nu/nu mouse ascites fluid as described (79). The 34A was radiolabeled with 125I using IDO-GEN (Pierce, Rockford, IL) method to a specific activity of 2 to 4 x 105 cpm/pg, and conjugated with NGPE as previously described (7). 

Radiolabel 55 nmol of SASD using IODO-GEN (Thermo Fisher) and 40 pCi Na 125I for 30 seconds. Do not use chloramine-T, since termination of the iodination reaction with this reagent involves addition of a reducing agent which may cleave the disulfide bonds of the crosslinker. 

These factors make 125I the iodine label of choice for radiolabeling biological molecules. Its commercial availability from a number of suppliers at relatively low cost further adds to its popularity. Even though it has lower specific activity than 131I, iodine-125 still provides much greater sensitivity than 14C, 32P, 35S, or 3H in labeling biomolecules. In fact, the use of a radioactive iodine label can create probes that have 150-fold more sensitivity than tritiated molecules and as much as 35,000 times the detectability of 14C-labeled molecules (Bolton and Hunter, 1986). 

The major requirements for photoactivatable amino acids are that they should exhibit high optical purity and contain appropriate protecting groups for solid-phase synthesis there is also a particular advantage if they contain the radiolabel. While p-azido-phenylalanines can easily be labeled with 125I and... 

Immunoradiometric assays (IRMAs) are like RIAs in that a radiolabeled substance is used in an antibody-antigen reaction, except that the radioactive label is attached to the antibody instead of the hormone. Furthermore, excess of antibody, rather than limited quantity, is present in the assay. All the unknown antigen becomes bound in an IRMA rather than just a portion, as in a RIA IRMAs are more sensitive. In the one-site assay, the excess antibody that is not bound to the sample is removed by addition of a precipitating binder. In a two-site assay, a molecule with at least two antibody-binding sites is adsorbed onto a solid phase, to which one of the antibodies is attached. After binding to this antibody is completed, a second antibody labeled with 125I is added to the assay. This antibody reacts with the second antibody-binding site to form a sandwich, composed of antibody-hormone-labeled antibody. The amount of hormone present is proportional to the amount of radioactivity measured in the assay. 

I-labeled hormone Allow time to react and wash away unbound radiolabeled hormone Yy y YYY... 

I-labeled secondary antibody. Secondaiy antibodies can be labeled as previously described (11) or purchased commercially. Radiolabeled antibodies should only be used by personnel trained to properly handle radioisotopes properly... 

---